NASDAQ: ABEO - Abeona Therapeutics Inc.

Lønnsomhet i seks måneder: -11.69%
Sektor: Healthcare

Kampanjeplan Abeona Therapeutics Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs.

Flere detaljer
The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Выручка 0.01
EBITDA -0.0672
Число акций ао 0.02138 млрд
P/S 14.55
P/BV 0.8184
EV/EBITDA -0.3678
Цена ао 7.36
ISIN US00289Y2063
Сайт https://www.abeonatherapeutics.com
Див.доход ао 8.55
Дивиденд ао 3706.25
Валюта usd
IPO date 1980-09-19
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Prisendring per dag: +2.98% (6.38)
Prisendring per uke: +11.54% (5.89)
Prisendring per måned: +16.7% (5.63)
Prisendring over 3 måneder: +36.88% (4.8)
Prisendring over seks måneder: -11.69% (7.44)
Prisendring per år: +58.31% (4.15)
Prisendring over 3 år: +456.78% (1.18)
Prisendring over 5 år: +326.62% (1.54)
Prisendring siden begynnelsen av året: +48.64% (4.42)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 30.36 1
P/BV 7.17 1
P/E 0 0
EV/EBITDA -2.16 0
Total: 3.5

Effektivitet

Navn Betydning Karakter
ROA, % -84.67 0
ROE, % -365.49 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 1 10
Total: 4.49

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.12 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 16.67 3
Lønnsomhet Ebitda, % -33.03 0
Lønnsomhet EPS, % -93.34 0
Total: 0.6
Flere detaljer

Institusjoner Volum Dele, %
Nantahala Capital Management, LLC 4500504 16.45
Adage Capital Partners GP L.L.C. 3249994 11.88
Millennium Management LLC 1418675 5.19
Vanguard Group Inc 1101131 4.03
Western Standard, LLC 808112 2.95
AIGH Capital Management LLC 787769 2.88
Point72 Asset Management, L.P. 760870 2.78
Ikarian Capital, LLC 600000 2.19
Citigroup Inc. 450347 1.65
J. Goldman & Co., L.P. 429816 1.57

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Neuroscience and Healthcare ETF 0.43711 19.720292847757 0.03
iShares Micro-Cap ETF 0.05965 36.318555985322 1.54048



Veileder Stillingstittel Betaling Fødselsår
Dr. Vishwas Seshadri M.B.A., Ph.D. President, CEO & Director 1.49M 1976 (48 år)
Mr. Brian Kevany Ph.D. Senior VP, CTO & CSO N/A
Mr. Gregory Gin Vice President of Investor Relations & Corporate Communications N/A
Ms. Alison Hardgrove Chief People Officer N/A
Mr. Jon Voss VP & Head of Quality N/A 1960 (64 år)
Dr. Madhav Vasanthavada M.B.A., Ph.D. Senior VP, Chief Commercial Officer & Head of Business Development N/A
Mr. Carl Denny Senior Vice President of Regulatory Affairs N/A
Mr. Joseph Walter Vazzano CPA Chief Financial Officer 920.85k 1984 (40 år)
Dr. Brendan M. O'Malley J.D., Ph.D. Senior VP & General Counsel 1970 (54 år)

Adresse: United States, New York. NY, 1330 Avenue of the Americas - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.abeonatherapeutics.com